Hyfinity Investments logo

Hyfinity Investments

Asia, Beijing, China, Beijing

Description

Hyfinity Investments is an investment Firm.

Investor Profile

Hyfinity Investments has made 3 investments, with 2 in the past 12 months and 67% as lead.

Stage Focus

  • Series C (67%)
  • Seed (33%)

Country Focus

  • China (67%)
  • Iceland (33%)

Industry Focus

  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Medical Device
  • Biotechnology
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hyfinity Investments frequently co-invest with?

Med-Fine Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Innovation and Technology Venture Fund
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Earlybird Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
BVCF
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 1
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 1
Sunmed Capital
Asia, Hainan, China, Sanya
Co-Investments: 1
Brunnur Ventures
Europe, Gullbringusysla, Iceland, Reykjavík
Co-Investments: 1
HC
Asia, Shanghai, China, Shanghai
Co-Investments: 1

What are some of recent deals done by Hyfinity Investments?

Jianda Biopharmaceuticals

Nanjing, Jiangsu, China

Jianda Biopharmaceuticals is a clinical-stage vaccine research and development company that develops innovative vaccines and new adjuvants.

Clinical TrialsHealth CarePharmaceutical
SeedJan 14, 2025
Amount Raised: $13,638,657
ZD Medical

Hangzhou, Zhejiang, China

ZD Medical is a medical device company that manufactures optical coherence tomography angiography devices.

ManufacturingMedical Device
Series CNov 1, 2024
Amount Raised: $14,039,817
Oculis

Reykjavík, Gullbringusysla, Iceland

Oculis is a clinical-stage biopharmaceutical development company focusing on ophthalmic drugs and novel drug delivery.

BiotechnologyHealth CarePharmaceutical
Series CMay 4, 2021
Amount Raised: $57,000,000